A Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced Cancers
Clinical trial NCT03400332 · COMPLETED
Trial details
- NCT number
- NCT03400332
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-12
- Primary completion
- 2024-04-26
- Enrollment
- 281
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.